Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 12 , Pages 947-956 , December 2011

Association of apolipoprotein A5 gene polymorphisms and serum lipid levels

  • Y.-Y. Li

      Affiliations

    • Department of Cardiology, Institute of Cardiovascular Diseases, The First Affiliated Hospital, Guangxi Medical University, Nanning 530021, Guangxi, PR China
    • Department of Cardiology, Guangxi National Hospital, Nanning, Guangxi, PR China
    • ,
  • R.-X. Yin

      Affiliations

    • Department of Cardiology, Institute of Cardiovascular Diseases, The First Affiliated Hospital, Guangxi Medical University, Nanning 530021, Guangxi, PR China
    • Corresponding Author InformationCorresponding author. Tel.: +86 771 5326125; fax: +86 771 5353342.
    • ,
  • C.-Q. Lai

      Affiliations

    • Nutrition and Genomics Laboratory, Jean Mayer USDA HNRCA, Tufts University, Boston, MA, USA
    • ,
  • M. Li

      Affiliations

    • Department of Internal Medicine, Worker’s Hospital of Guangxi Liuzhou Iron and Steel (Group) Company, Liuzhou, Guangxi, PR China
    • ,
  • X.-J. Long

      Affiliations

    • Department of Cardiology, Institute of Cardiovascular Diseases, The First Affiliated Hospital, Guangxi Medical University, Nanning 530021, Guangxi, PR China
    • ,
  • K.-L. Li

      Affiliations

    • Department of Cardiology, Institute of Cardiovascular Diseases, The First Affiliated Hospital, Guangxi Medical University, Nanning 530021, Guangxi, PR China
    • ,
  • W.-Y. Liu

      Affiliations

    • Department of Cardiology, Institute of Cardiovascular Diseases, The First Affiliated Hospital, Guangxi Medical University, Nanning 530021, Guangxi, PR China
    • ,
  • L. Zhang

      Affiliations

    • Department of Cardiology, Institute of Cardiovascular Diseases, The First Affiliated Hospital, Guangxi Medical University, Nanning 530021, Guangxi, PR China
    • ,
  • J.-Z. Wu

      Affiliations

    • Department of Cardiology, Institute of Cardiovascular Diseases, The First Affiliated Hospital, Guangxi Medical University, Nanning 530021, Guangxi, PR China

Received 23 October 2009 ,Revised 22 February 2010 ,Accepted 13 April 2010.

References 

  1. Shekelle RB, Shryock AM, Paul O, Lepper M, Stamler J, Liu S, et al. Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. N Engl J Med. 1981;304:65–70
  2. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation. 1998;97:1029–1036
  3. Achari V, Thakur AK. Association of major modifiable risk factors among patients with coronary artery disease – a retrospective analysis. J Assoc Physicians India. 2004;52:103–108
  4. Durrington PN, Hunt L, Ishola M, Kane J, Stephens WP. Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction. Br Heart J. 1986;56:206–212
  5. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79:8–15
  6. Wu LL. Review of risk factors for cardiovascular diseases. Ann Clin Lab Sci. 1999;29:127–133
  7. Pérusse L, Rice T, Després JP, Bergeron J, Province MA, Gagnon J, et al. Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE Family Study. Arterioscler Thromb Vasc Biol. 1997;17:3263–3269
  8. Ishihara M, Kujiraoka T, Iwasaki T, Nagano M, Takano M, Ishii J, et al. A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A–V concentration. J Lipid Res. 2005;46:2015–2022
  9. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001;294:169–173
  10. Endo K, Yanagi H, Araki J, Hirano C, Yamakawa-Kobayashi K, Tomura S. Association found between the promoter region polymorphism in the apolipoprotein A–V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet. 2002;111:570–572
  11. Van der Vliet HN, Schaap FG, Levels JH, Ottenhoff R, Looije N, Wesseling JG, et al. Adenovirus overexpression of apolipoprotein A–V reduces serum levels of triglycerides and cholesterol in mice. Biochem Biophys Res Commun. 2002;295:1156–1159
  12. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet. 2001;11:3031–3038
  13. Nabika T, Nasreen S, Kobayashi S, Masuda J. The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis. 2002;165:201–204
  14. Lai CQ, Tai ES, Tan CE, Cutter J, Chew SK, Zhu YP, et al. The ApoA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res. 2003;44:2365–2373
  15. Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, Rubin EM, et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet. 2002;11:3039–3046
  16. Aouizerat BE, Kulkarni M, Heilbron D, Drown D, Raskin S, Pullinger CR, et al. Genetic analysis of a polymorphism in the human apoA–V gene: effect on plasma lipids. J Lipid Res. 2003;44:1167–1173
  17. Baum L, Tomlinson B, Thomas GN. ApoA5 −1131T>C polymorphism is associated with triglyceride levels in Chinese men. Clin Genet. 2003;63:377–379
  18. Kao JT, Wen HC, Chien KL, Hsu HC, Lin SW. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet. 2003;12:2533–2539
  19. Chaaba R, Attia N, Hammami S, Smaoui M, Mahjoub S, Hammami M, et al. Association of SNP3 polymorphism in the apolipoprotein A–V gene with plasma triglyceride level in Tunisian type 2 diabetes. Lipids Health Dis. 2005;4:1
  20. Lai CQ, Demissie S, Cupples LA, Zhu Y, Adiconis X, Parnell LD, et al. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res. 2004;45:2096–2105
  21. Liu H, Zhang S, Lin J, Li H, Huang A, Xiao C, et al. Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism. 2005;54:568–572
  22. Hsu LA, Ko YL, Chang CJ, Hu CF, Wu S, Teng MS, et al. Genetic variation of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis. 2006;185:143–149
  23. Tang Y, Sun P, Guo D, Ferro A, Ji Y, Chen Q, et al. A genetic variant c.553G>T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis. 2006;185:433–437
  24. Lee KWJ, Ayyobi AF, Frohlich JJ, Hill JS. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease. Atherosclerosis. 2004;176:165–172
  25. Ribalta J, Figuera L, Fernandez-Ballart J, Vilella E, Castro Cabezas M, Masana L, et al. Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem. 2002;48:1597–1600
  26. Ruixing Y, Yuming C, Shangling P, Fengping H, Tangwei L, Dezhai Y, et al. Effects of demographic, dietary and other lifestyle factors on the prevalence of hyperlipidemia in Guangxi Hei Yi Zhuang and Han populations. Eur J Cardiovasc Prev Rehabil. 2006;13:977–984
  27. Ruixing Y, Limei Y, Yuming C, Dezhai Y, Weixiong L, Muyan L, et al. Prevalence, awareness, treatment, control and risk factors of hypertension in the Guangxi Hei Yi Zhuang and Han populations. Hypertens Res. 2006;29:423–432
  28. Hubácek JA, Adámková V, Ceska R, Poledne R, Horínek A, Vráblík M. New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels. Physiol Res. 2004;53:225–228
  29. Hubacek JA, Adamkova V, Prusikova M, Snejdrlova M, Hirschfeldova K, Lanska V, et al. Impact of apolipoprotein A5 variants on statin treatment efficacy. Pharmacogenomics. 2009;10:945–950
  30. Humphries S, Talmud P, Monsalve V, McKeigue P. RFLP studies in different ethnic groups. Atherosclerosis. 1989;75:249–250

PII: S0939-4753(10)00102-X

doi: 10.1016/j.numecd.2010.04.004

Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 12 , Pages 947-956 , December 2011

Article Tools

* Image Usage & Resolution